Biotage AB Nomination Committee

A Nomination Committee consisting of shareholder representatives and the Chairman of the Board of Directors has been formed for Biotage AB. The Nomination Committee shall, before the Annual General Meeting 2010, prepare proposals for the election of Chairman and other members of the Board of Directors, the election of Chairman of the Annual General Meeting, the determination of fees and matters pertaining thereto. The members of the Nomination Committee are: Björn Odlander, HealthCap Karl Swartling, Investor Growth Capital Anders Walldow, Brohuvudet AB and direct holding Ove Mattsson, Chairman of the Board Shareholders wishing to submit a proposal for members of the Board of Directors may do so sending e-mail to the Chairman of the Board of Directors of Biotage AB at

About Us

Biotage offers efficient separation technologies from analysis to industrial-scale and high-quality solutions for analytical chemistry from research to commercial analysis laboratories. Biotage’s products are used by public authorities, academic institutions, contract research and contract manufacturing organizations and in the pharmaceutical and food industries, among others. The company is headquartered in Uppsala and has offices in the US, UK, China, Japan, South Korea and India. Biotage has approx. 390 employees and had sales of 748 MSEK in 2017. Biotage is listed on Nasdaq Stockholm. Website:


Documents & Links